GLUE

Monte Rosa Therapeutics, Inc.

4.33 USD
+0.01 (+0.23%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fundamentals

Fundamental data refers to the information about the company itself, its financial state, sales and revenues, profitability and growth. This is a set of metrics used by financial analysts to gauge the financial health of an organization as well as its future prospects. This page will include information about many of the common fundamental metrics and KPIs used to evaluate and price the value of public corporations in the United States and around the world.

Market-Cap 

358.10M USD

Enterprise Value 

171.80M USD

Price to Earnings Ratio (ttm) 

-2.7

Price to Book Value 

2.0

EV/EBITDA 

-1.2

Revenue 

1.06M USD

Operating Expenses 

-36.01M USD

Net Income 

-31.97M USD

Earnings Per Share, Basic 

-0.53 USD

Earnings Per Share, Diluted 

-0.53 USD

EBITDA 

-33.05M USD

Shares (Basic) 

60,156,187.00

Shares (Diluted) 

60,156,187.00

Price to Sales Ratio (ttm) 

0.0

Cost of Revenue 

0.00 USD

Gross Profit 

0.00 USD